1. Home
  2. TKNO vs DOMO Comparison

TKNO vs DOMO Comparison

Compare TKNO & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • DOMO
  • Stock Information
  • Founded
  • TKNO 1996
  • DOMO 2010
  • Country
  • TKNO United States
  • DOMO United States
  • Employees
  • TKNO N/A
  • DOMO N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • TKNO Health Care
  • DOMO Technology
  • Exchange
  • TKNO Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • TKNO 356.4M
  • DOMO 324.2M
  • IPO Year
  • TKNO 2021
  • DOMO 2018
  • Fundamental
  • Price
  • TKNO $6.96
  • DOMO $8.19
  • Analyst Decision
  • TKNO Buy
  • DOMO Hold
  • Analyst Count
  • TKNO 1
  • DOMO 6
  • Target Price
  • TKNO $5.00
  • DOMO $10.25
  • AVG Volume (30 Days)
  • TKNO 431.4K
  • DOMO 297.1K
  • Earning Date
  • TKNO 05-08-2025
  • DOMO 05-22-2025
  • Dividend Yield
  • TKNO N/A
  • DOMO N/A
  • EPS Growth
  • TKNO N/A
  • DOMO N/A
  • EPS
  • TKNO N/A
  • DOMO N/A
  • Revenue
  • TKNO $38,250,000.00
  • DOMO $317,044,000.00
  • Revenue This Year
  • TKNO $9.58
  • DOMO $0.86
  • Revenue Next Year
  • TKNO $15.97
  • DOMO $1.58
  • P/E Ratio
  • TKNO N/A
  • DOMO N/A
  • Revenue Growth
  • TKNO 3.79
  • DOMO N/A
  • 52 Week Low
  • TKNO $1.16
  • DOMO $6.01
  • 52 Week High
  • TKNO $10.37
  • DOMO $10.15
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 63.43
  • DOMO 58.20
  • Support Level
  • TKNO $5.70
  • DOMO $7.41
  • Resistance Level
  • TKNO $6.85
  • DOMO $7.97
  • Average True Range (ATR)
  • TKNO 0.50
  • DOMO 0.33
  • MACD
  • TKNO 0.03
  • DOMO 0.11
  • Stochastic Oscillator
  • TKNO 70.79
  • DOMO 87.22

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: